A comparative evaluation of prosthetic and biological outcome of two different implant restorative materials
- Conditions
- Health Condition 1: K055- Other periodontal diseases
- Registration Number
- CTRI/2022/02/039915
- Lead Sponsor
- Taniya Malhotra
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1.Two implants placed in the same arch in posterior quadrant requiring prosthodontic rehabilitation.
2.Interocclusal restorative space of 8-10 mm
3.Healthy Periodontium with no visible signs of bruxism
4.Stable and healthy implants with no crestal bone loss
1. According to ASA Classification Class 4 patients:
Organic heart disease with marked signs of cardiac insufficiency
Recent myocardial infarction of less than 6 months duration.
Unstable angina.
Patients with advanced degrees of pulmonary, renal or endocrine insufficiency
2. According to ASA Classification Class 3 patients
Diabetes with complications to vascular or other organs, i.e., retinopathy, neuropathy, etc.
3. Occlusal anomalies
Deep Bite
Cross Bite
4. Long term edentulism leading to mesial drifting of adjacent teeth or supraaeruption of opposing teeth
5.Para-functional Habits (Bruxism)
6.Smokers
7.Active periodontal disease
8.Allergy to materials used in the study
9.Current drug abuse
10.Pregnant or intend to become pregnant.
11.Severe salivary gland dysfunction.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method primary outcome will determine which restoration will be more suitable for implant supported prosthesis. <br/ ><br>The suitabilty of the restorations will depend on the prosthetic and biologic outcome which will include ceramic fracture, screw loosening, marginal fit, color match, occlusal wear, bleeding on probing, plaque deposition etcTimepoint: primary outcome will determined at baseline, 6 months and 12 months
- Secondary Outcome Measures
Name Time Method To Determine the biological outcome through evaluation of inflammatory markers of two different implant restorative materials. The inflammatory marker to be evaluated is MMP-8.Timepoint: Biological outcome will be assessed at baseline, 6 months and 12 months